Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,976 DKK | +2.00% | +2.28% | -7.22% |
06:46am | Genmab Announces Initial Data from Phase 2 Cancer Treatment Trial | MT |
05-21 | Genmab A/S Reaffirms Financial Guidance for 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.22% | 18.16B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-1.37% | 21.96B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B | |
+7.26% | 7.75B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Transcript : Genmab A/S, H1 2022 Earnings Call, Aug 10, 2022